LARRY LUX: Open Payments
NPI 1245446947 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 44 payments from 15 companies in 2025. Trend: 2023 $1,079 · 2024 $983 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $162 |
| ABBVIE INC. | 8 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| Lilly USA, LLC | 6 | $130 |
| Abbott Laboratories | 4 | $88 |
| PFIZER INC. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Astellas Pharma US Inc | 2 | $36 |
| Amgen Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Ozempic, MOUNJARO, QULIPTA, FREESTYLE LIBRE 3, AIRSUPRA, PREVNAR 20, XIFAXAN, UBRELVY.
Industry payments across KS — which companies pay providers there.
